30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

bluebird bio Inc (BLUE)

Track

Stock chart
Ticker: BLUE Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Colvin Richard A
Chief Medical Officer
2 sales — total 4,574 USD
Sale 3 Mar 2025
Value US$2,859,940.17 | Price 305.70 | Shares 24,686
Proposed sale 3 Mar 2025
Value US$390,282.07 | Price 318.28 | Shares 92,349
Sale 3 Mar 2025
Value US$4,960,429.32 | Price 416.12 | Shares 70,353
Proposed sale 3 Mar 2025
Value US$3,241,109.64 | Price 157.57 | Shares 79,486
Sale 3 Mar 2025
Value US$3,609.77 | Price 3.92 | Shares 921
Proposed sale 3 Mar 2025
Value US$3,604.18 | Price 3.91 | Shares 921
Sale 3 Feb 2025
Value US$901.88 | Price 7.39 | Shares 122
Proposed sale 3 Feb 2025
Value US$943.87 | Price 7.74 | Shares 122
Sale 3 Feb 2025
Value US$635.76 | Price 7.39 | Shares 86
Proposed sale 3 Feb 2025
Value US$665.35 | Price 7.74 | Shares 86
Sale 3 Feb 2025
Value US$1,759.42 | Price 7.39 | Shares 238
Proposed sale 3 Feb 2025
Value US$1,841.33 | Price 7.74 | Shares 238
Sale 3 Feb 2025
Value US$473.12 | Price 7.39 | Shares 64
Proposed sale 3 Feb 2025
Value US$495.15 | Price 7.74 | Shares 64
Sale 6 Jan 2025
Value US$175.56 | Price 9.24 | Shares 19
Proposed sale 6 Jan 2025
Value US$166.00 | Price 8.74 | Shares 19
Sale 6 Jan 2025
Value US$1,293.60 | Price 9.24 | Shares 140
Proposed sale 6 Jan 2025
Value US$1,223.13 | Price 8.74 | Shares 140
Sale 10 Dec 2024
Value US$405.20 | Price 0.42 | Shares 971
Proposed sale 10 Dec 2024
Value US$436.95 | Price 0.45 | Shares 971
Sale 10 Dec 2024
Value US$1,178.46 | Price 0.42 | Shares 2,824
Proposed sale 10 Dec 2024
Value US$1,270.80 | Price 0.45 | Shares 2,824
Sale 30 Sep 2024
Value US$528.85 | Price 0.53 | Shares 1,006
Proposed sale 30 Sep 2024
Value US$523.12 | Price 0.52 | Shares 1,006
Sale 30 Sep 2024
Value US$18,269.93 | Price 0.53 | Shares 34,780
Proposed sale 30 Sep 2024
Value US$18,085.60 | Price 0.52 | Shares 34,780
Sale 3 Jun 2024
Value US$3,726.26 | Price 0.97 | Shares 3,834
Sale 4 Mar 2024
Value US$6,985.71 | Price 1.53 | Shares 4,573
Sale 4 Mar 2024
Value US$9,310.72 | Price 1.53 | Shares 6,095
Sale 1 Mar 2024
Value US$10,341.85 | Price 1.53 | Shares 6,770
Sale 5 Feb 2024
Value US$2,449.38 | Price 0.90 | Shares 2,714
Sale 5 Feb 2024
Value US$1,695.80 | Price 0.90 | Shares 1,879
Sale 5 Feb 2024
Value US$4,708.34 | Price 0.90 | Shares 5,217
Sale 5 Jan 2024
Value US$844.76 | Price 1.42 | Shares 597
Sale 5 Jan 2024
Value US$4,519.76 | Price 1.43 | Shares 3,162
Sale 6 Dec 2023
Value US$20,437.15 | Price 4.52 | Shares 4,526
Sale 3 Nov 2023
Value US$2,554.88 | Price 3.17 | Shares 807
Sale 2 Nov 2023
Value US$6,974.88 | Price 2.98 | Shares 2,343
Sale 5 Sep 2023
Value US$3,493.09 | Price 3.79 | Shares 922
Sale 10 Aug 2023
Value US$59,955.75 | Price 3.54 | Shares 16,929
Sale 2 Jun 2023
Value US$14,450.87 | Price 3.50 | Shares 4,130
Sale 11 Jan 2023
Value US$33,480.45 | Price 7.80 | Shares 4,290
Sale 11 Jan 2023
Value US$4,347.00 | Price 7.80 | Shares 557
Sale 11 Jan 2023
Value US$24,802.07 | Price 7.80 | Shares 3,178
Sale 4 Nov 2022
Value US$1,398.19 | Price 6.41 | Shares 218
Sale 4 Nov 2022
Value US$8,100.50 | Price 6.41 | Shares 1,263
Sale 17 Oct 2022
Value US$6,490.16 | Price 6.46 | Shares 1,004
Sale 19 Aug 2022
Value US$78,472.95 | Price 5.53 | Shares 14,194
Sale 4 Aug 2022
Value US$95,754.48 | Price 4.39 | Shares 21,805
Sale 4 Aug 2022
Value US$32,707.15 | Price 4.39 | Shares 7,448
Sale 12 Jul 2022
Value US$6,722.10 | Price 4.95 | Shares 1,358
Sale 3 Jun 2022
Value US$11,535.22 | Price 3.07 | Shares 3,753
Sale 11 Jan 2022
Value US$45,156.30 | Price 9.64 | Shares 4,683
Sale 11 Jan 2022
Value US$2,690.29 | Price 9.64 | Shares 279
Sale 11 Jan 2022
Value US$32,659.49 | Price 9.64 | Shares 3,387
Sale 11 Jan 2022
Value US$48,868.70 | Price 9.64 | Shares 5,068
Sale 10 Jan 2022
Value US$20,590.82 | Price 9.40 | Shares 2,190
Sale 10 Jan 2022
Value US$7,876.31 | Price 9.24 | Shares 852
Sale 10 Jan 2022
Value US$1,222.29 | Price 9.40 | Shares 130
Sale 10 Jan 2022
Value US$14,893.08 | Price 9.40 | Shares 1,584
Sale 10 Jan 2022
Value US$22,273.81 | Price 9.40 | Shares 2,369
Sale 5 Jan 2022
Value US$31,143.41 | Price 10.44 | Shares 2,984
Sale 7 Dec 2021
Value US$8,469.26 | Price 10.18 | Shares 832
Sale 4 Jun 2021
Value US$15,715.24 | Price 30.75 | Shares 511
Sale 3 May 2021
Value US$13,387.09 | Price 30.15 | Shares 444
Sale 3 May 2021
Value US$874.38 | Price 30.15 | Shares 29
Sale 5 Apr 2021
Value US$875.95 | Price 30.21 | Shares 29
Sale 5 Apr 2021
Value US$1,117.59 | Price 30.21 | Shares 37
Sale 5 Apr 2021
Value US$1,178.00 | Price 30.21 | Shares 39
Sale 2 Mar 2021
Value US$1,242.44 | Price 29.58 | Shares 42
Sale 2 Mar 2021
Value US$1,124.11 | Price 29.58 | Shares 38
Sale 2 Mar 2021
Value US$1,153.69 | Price 29.58 | Shares 39
Sale 2 Mar 2021
Value US$13,134.36 | Price 29.58 | Shares 444
Sale 2 Mar 2021
Value US$1,005.78 | Price 29.58 | Shares 34
Sale 17 Feb 2021
Value US$18,699.10 | Price 28.16 | Shares 664
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-05 2025-03-03 S Sale
3.8
Colvin Richard A

Chief Medical Officer

Officer
24,686 -42.4%
305.70
US$2,859,940 		24,686 -42.4% 305.70 US$2,859,940
2025-03-05 2025-03-03 S Sale
2.6
Klima Thomas J

See Remarks

Officer
70,353 -20.2%
416.12
US$4,960,429 		70,353 -20.2% 416.12 US$4,960,429
2025-03-05 2025-03-03 S Sale
2.8
Obenshain Andrew

President and CEO

Executive Director
7,640 +21.5%
99.50
US$4,400,604 		7,640 +21.5% 99.50 US$4,400,604
2025-03-03 2025-03-03 PrS Proposed sale
2.8
Obenshain Andrew

Officer; Director

Executive Director
921
3.91
US$3,604 		921 3.91 US$3,604
2025-03-03 2025-03-03 PrS Proposed sale
2.6
Klima Thomas J

Officer

Officer
500
3.91
US$1,957 		500 3.91 US$1,957
2025-03-03 2025-03-03 PrS Proposed sale
3.8
Colvin Richard A

Officer

Officer
584
3.91
US$2,285 		584 3.91 US$2,285
2025-02-05 2025-02-03 S Sale
2.6
Klima Thomas J

See Remarks

Officer
122 -1.4%
7.39
US$902 		122 -1.4% 7.39 US$902
2025-02-05 2025-02-03 S Sale
2.8
Obenshain Andrew

President and CEO

Executive Director
86 -0.5%
7.39
US$636 		86 -0.5% 7.39 US$636
2025-02-05 2025-02-03 S Sale
3.0
Vittiglio Joseph

Chief Business & Legal Officer

Officer
238 -5.0%
7.39
US$1,759 		238 -5.0% 7.39 US$1,759
2025-02-05 2025-02-03 S Sale
3.8
Colvin Richard A

Chief Medical Officer

Officer
64 -0.8%
7.39
US$473 		64 -0.8% 7.39 US$473
2025-02-03 2025-02-03 PrS Proposed sale
2.8
Obenshain Andrew

Officer; Director

Executive Director
86
7.74
US$665 		86 7.74 US$665
2025-02-03 2025-02-03 PrS Proposed sale
2.6
Klima Thomas J

Officer

Officer
122
7.74
US$944 		122 7.74 US$944
2025-02-03 2025-02-03 PrS Proposed sale
3.8
Colvin Richard A

Officer

Officer
64
7.74
US$495 		64 7.74 US$495
2025-02-03 2025-02-03 PrS Proposed sale
3.0
Vittiglio Joseph

Officer

Officer
238
7.74
US$1,841 		238 7.74 US$1,841
2025-01-08 2025-01-06 S Sale
3.8
Colvin Richard A

Chief Medical Officer

Officer
19 -0.2%
9.24
US$176 		19 -0.2% 9.24 US$176
2025-01-08 2025-01-06 S Sale
2.8
Obenshain Andrew

President and CEO

Executive Director
140 -0.7%
9.24
US$1,294 		140 -0.7% 9.24 US$1,294
2025-01-07 2025-01-06 PrS Proposed sale
3.8
Colvin Richard A

Officer

Officer
19
8.74
US$166 		19 8.74 US$166
2025-01-06 2025-01-06 PrS Proposed sale
2.8
Obenshain Andrew

Officer; Director

Executive Director
140
8.74
US$1,223 		140 8.74 US$1,223
2024-12-12 2024-12-10 S Sale
2.8
Obenshain Andrew

President and CEO

Executive Director
971 -0.3%
0.42
US$405 		971 -0.3% 0.42 US$405
2024-12-12 2024-12-10 S Sale
3.8
Colvin Richard A

Chief Medical Officer

Officer
2,824 -1.7%
0.42
US$1,178 		2,824 -1.7% 0.42 US$1,178
2024-12-10 2024-12-10 PrS Proposed sale
3.8
Colvin Richard A

Officer

Officer
2,824
0.45
US$1,271 		2,824 0.45 US$1,271
2024-12-10 2024-12-10 PrS Proposed sale
2.8
Obenshain Andrew

Officer; Director

Executive Director
971
0.45
US$437 		971 0.45 US$437
2024-10-02 2024-09-30 S Sale
2.6
Klima Thomas J

See Remarks

Officer
1,006 -0.6%
0.53
US$529 		1,006 -0.6% 0.53 US$529
2024-10-02 2024-09-30 S Sale
2.8
Obenshain Andrew

President and CEO

Executive Director
34,780 -8.5%
0.53
US$18,270 		34,780 -8.5% 0.53 US$18,270
2024-10-01 2024-09-30 PrS Proposed sale
2.8
Obenshain Andrew

Officer; Director

Executive Director
34,780
0.52
US$18,086 		34,780 0.52 US$18,086
2024-10-01 2024-09-30 PrS Proposed sale
2.6
Klima Thomas J

Officer

Officer
1,006
0.52
US$523 		1,006 0.52 US$523
2024-06-04 2024-06-03 S Sale
2.6
Klima Thomas J

See Remarks

Officer
3,834 -3.1%
0.97
US$3,726 		3,834 -3.1% 0.97 US$3,726
2024-03-05 2024-03-04 S Sale
2.6
Klima Thomas J

See Remarks

Officer
4,573 -3.5%
1.53
US$6,986 		4,573 -3.5% 1.53 US$6,986
2024-03-05 2024-03-04 S Sale
2.8
Obenshain Andrew

President and CEO

Executive Director
6,095 -2.1%
1.53
US$9,311 		6,095 -2.1% 1.53 US$9,311
2024-03-05 2024-03-01 S Sale
3.8
Colvin Richard A

Chief Medical Officer

Officer
6,770 -5.4%
1.53
US$10,342 		6,770 -5.4% 1.53 US$10,342
2024-02-06 2024-02-05 S Sale
2.6
Klima Thomas J

See Remarks

Officer
2,714 -2.1%
0.90
US$2,449 		2,714 -2.1% 0.90 US$2,449
2024-02-06 2024-02-05 S Sale
2.8
Obenshain Andrew

President and CEO

Executive Director
1,879 -0.7%
0.90
US$1,696 		1,879 -0.7% 0.90 US$1,696
2024-02-06 2024-02-05 S Sale
3.0
Vittiglio Joseph

Chief Business & Legal Officer

Officer
5,217 -10.4%
0.90
US$4,708 		5,217 -10.4% 0.90 US$4,708
2024-01-09 2024-01-05 S Sale
3.8
Colvin Richard A

Chief Medical Officer

Officer
597 -0.5%
1.42
US$845 		597 -0.5% 1.42 US$845
2024-01-09 2024-01-05 S Sale
2.8
Obenshain Andrew

President and CEO

Executive Director
3,162 -1.1%
1.43
US$4,520 		3,162 -1.1% 1.43 US$4,520
2023-12-08 2023-12-06 S Sale
3.3
Krawtschuk Christopher

Chief Financial Officer

Officer
4,526 -9.1%
4.52
US$20,437 		4,526 -9.1% 4.52 US$20,437
2023-11-03 2023-11-03 S Sale
2.8
Obenshain Andrew

President and CEO

Executive Director
807 -0.3%
3.17
US$2,555 		807 -0.3% 3.17 US$2,555
2023-11-03 2023-11-02 S Sale
3.8
Colvin Richard A

Chief Medical Officer

Officer
2,343 -1.8%
2.98
US$6,975 		2,343 -1.8% 2.98 US$6,975
2023-09-06 2023-09-05 S Sale
2.6
Klima Thomas J

See Remarks

Officer
922 -0.7%
3.79
US$3,493 		922 -0.7% 3.79 US$3,493
2023-08-10 2023-08-10 S Sale
2.8
Obenshain Andrew

President and CEO

Executive Director
16,929 -5.5%
3.54
US$59,956 		16,929 -5.5% 3.54 US$59,956
2023-06-06 2023-06-02 S Sale
2.6
Klima Thomas J

See Remarks

Officer
4,130 -3.0%
3.50
US$14,451 		4,130 -3.0% 3.50 US$14,451
2023-01-13 2023-01-11 S Sale
3.2
Leschly Nick
Non-Executive Director
4,290 -1.5%
7.80
US$33,480 		4,290 -1.5% 7.80 US$33,480
2023-01-13 2023-01-11 S Sale
3.8
Colvin Richard A

Chief Medical Officer

Officer
557 -0.7%
7.80
US$4,347 		557 -0.7% 7.80 US$4,347
2023-01-13 2023-01-11 S Sale
2.8
Obenshain Andrew

President and CEO

Executive Director
3,178 -1.3%
7.80
US$24,802 		3,178 -1.3% 7.80 US$24,802
2022-11-08 2022-11-04 S Sale
3.8
Colvin Richard A

Chief Medical Officer

Officer
218 -0.3%
6.41
US$1,398 		218 -0.3% 6.41 US$1,398
2022-11-08 2022-11-04 S Sale
2.8
Obenshain Andrew

President and CEO

Executive Director
1,263 -0.5%
6.41
US$8,101 		1,263 -0.5% 6.41 US$8,101
2023-03-09 2022-10-17 S Sale
1.4
Leiderman Elisabeth
Non-Executive Director
1,004 -8.1%
6.46
US$6,490 		1,004 -8.1% 6.46 US$6,490
2022-08-23 2022-08-19 S Sale
3.1
Cole Jason

Chief Strategy & Financial Off

Officer
14,194 -7.0%
5.53
US$78,473 		14,194 -7.0% 5.53 US$78,473
2022-08-08 2022-08-04 S Sale
2.8
Obenshain Andrew

President and CEO

Executive Director
21,805 -8.1%
4.39
US$95,754 		21,805 -8.1% 4.39 US$95,754
2022-08-08 2022-08-04 S Sale
3.1
Cole Jason

Chief Strategy & Financial Off

Officer
7,448 -3.5%
4.39
US$32,707 		7,448 -3.5% 4.39 US$32,707
2022-07-14 2022-07-12 S Sale
0.5
Eggimann Anne-Virginie

Chief Regulatory Officer

Officer
1,358 -3.1%
4.95
US$6,722 		1,358 -3.1% 4.95 US$6,722
2022-06-07 2022-06-03 S Sale
2.6
Klima Thomas J

Chief Commercial Officer

Officer
3,753 -5.0%
3.07
US$11,535 		3,753 -5.0% 3.07 US$11,535
2022-01-12 2022-01-11 S Sale
2.8
Obenshain Andrew

President and CEO

Executive Director
4,683 -1.9%
9.64
US$45,156 		4,683 -1.9% 9.64 US$45,156
2022-01-12 2022-01-11 S Sale
3.7
Whitten Jessica

Chief Accounting Officer

Officer
279 -0.6%
9.64
US$2,690 		279 -0.6% 9.64 US$2,690
2022-01-12 2022-01-11 S Sale
3.1
Cole Jason

Chief Operating and

Officer
3,387 -1.8%
9.64
US$32,659 		3,387 -1.8% 9.64 US$32,659
2022-01-12 2022-01-11 S Sale
3.2
Leschly Nick
Non-Executive Director
5,068 -1.8%
9.64
US$48,869 		5,068 -1.8% 9.64 US$48,869
2022-01-12 2022-01-10 S Sale
2.8
Obenshain Andrew

President and CEO

Executive Director
2,190 -0.9%
9.40
US$20,591 		2,190 -0.9% 9.40 US$20,591
2022-01-12 2022-01-10 S Sale
2.8
Obenshain Andrew

President and CEO

Executive Director
852 -0.3%
9.24
US$7,876 		852 -0.3% 9.24 US$7,876
2022-01-12 2022-01-10 S Sale
3.7
Whitten Jessica

Chief Accounting Officer

Officer
130 -0.3%
9.40
US$1,222 		130 -0.3% 9.40 US$1,222
2022-01-12 2022-01-10 S Sale
3.1
Cole Jason

Chief Operating and

Officer
1,584 -0.8%
9.40
US$14,893 		1,584 -0.8% 9.40 US$14,893
2022-01-12 2022-01-10 S Sale
3.2
Leschly Nick
Non-Executive Director
2,369 -0.8%
9.40
US$22,274 		2,369 -0.8% 9.40 US$22,274
2022-01-07 2022-01-05 S Sale
3.7
Whitten Jessica

Chief Accounting Officer

Officer
2,984 -5.7%
10.44
US$31,143 		2,984 -5.7% 10.44 US$31,143
2021-12-09 2021-12-07 S Sale
2.8
Obenshain Andrew

President and CEO

Executive Director
832 -0.3%
10.18
US$8,469 		832 -0.3% 10.18 US$8,469
2021-06-08 2021-06-04 S Sale
2.8
Obenshain Andrew

President of SGD

Officer
511 -1.3%
30.75
US$15,715 		511 -1.3% 30.75 US$15,715
2021-05-05 2021-05-03 S Sale
3.2
Leschly Nick

President and CEO

Executive Director
444 -0.1%
30.15
US$13,387 		444 -0.1% 30.15 US$13,387
2021-05-05 2021-05-03 S Sale
2.8
Obenshain Andrew

President of SGD

Officer
29 -0.1%
30.15
US$874 		29 -0.1% 30.15 US$874
2021-04-07 2021-04-05 S Sale
2.8
Obenshain Andrew

President of SGD

Officer
29 -0.1%
30.21
US$876 		29 -0.1% 30.21 US$876
2021-04-07 2021-04-05 S Sale
3.1
Cole Jason

Chief Operating and

Officer
37 -0.1%
30.21
US$1,118 		37 -0.1% 30.21 US$1,118
2021-04-07 2021-04-05 S Sale
3.3
Gregory Philip D

Chief Scientific Officer

Officer
39 -0.1%
30.21
US$1,178 		39 -0.1% 30.21 US$1,178
2021-03-04 2021-03-02 S Sale
3.3
Davidson David

Chief Medical Officer

Officer
42 -0.1%
29.58
US$1,242 		42 -0.1% 29.58 US$1,242
2021-03-04 2021-03-02 S Sale
3.1
Cole Jason

Chief Operating and

Officer
38 -0.1%
29.58
US$1,124 		38 -0.1% 29.58 US$1,124
2021-03-04 2021-03-02 S Sale
3.3
Gregory Philip D

Chief Scientific Officer

Officer
39 -0.1%
29.58
US$1,154 		39 -0.1% 29.58 US$1,154
2021-03-04 2021-03-02 S Sale
3.2
Leschly Nick

President and CEO

Executive Director
444 -0.4%
29.58
US$13,134 		444 -0.4% 29.58 US$13,134
2021-03-04 2021-03-02 S Sale
2.8
Obenshain Andrew

President of SGD

Officer
34 -0.1%
29.58
US$1,006 		34 -0.1% 29.58 US$1,006
2021-02-18 2021-02-17 S Sale
3.3
Gregory Philip D

Chief Scientific Officer

Officer
664 -1.4%
28.16
US$18,699 		664 -1.4% 28.16 US$18,699
Explore more

More insider trading research around bluebird bio Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America